Targeting mitochondria as a therapeutic target in cancer

Journal of Cellular Physiology

Volumn 227, Issue 2, 2012, Pages 450-456

  Wenner, Charles E ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; CALCIUM; CYCLOPHILIN; CYCLOPHILIN D; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR; INITIATION FACTOR 4E; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR FOXO; VOLTAGE DEPENDENT ANION CHANNEL; XESTOSPONGIN C;

ANAEROBIC GLYCOLYSIS; APOPTOSIS; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL; CELL ACTIVITY; CELL METABOLISM; CELL PROTECTION; CELL SURVIVAL; CHEMOPROPHYLAXIS; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; GROWTH INHIBITION; HUMAN; HYPOXIA; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; SHORT SURVEY;

ANIMALS; ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOCHONDRIA; NEOPLASMS;

EID: 80055041172     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22788     Document Type: Short Survey

References (52)

1. Azad MB, Chen Y, Gibson SB. 2009. Regulation of autophagy by reactive oxygen species (ROS): Implications for cancer progression and treatment. Antioxid Redox Signal 11: 777-790.
2. Berridge MV, Herst PM, Lawen A. 2009. Targeting mitochondrial permeability in cancer drug development. Mol Nutr Food Res 53: 76-86.
3. Berridge MV, Herst PM, Tan S. 2010. Metabolic flexibility and cell hierarchy in metastatic cancer. Mitochondrion 10: 584-588.
4. Bhaskar PT, Nogueira V, Patra KC, Jeon SM, Park Y, Robey RB, Hay N. 2009. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3{beta} inhibition. Mol Cell Biol 29: 5136-5147.
5. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. 2007. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67: 6745-6752.
6. Cagnol S, Chambard J-C. 2010. ERK and cell death: Mechanisms of ERK-induced cell death-Apoptosis, autophagy and senescence. FEBS J 277: 2-21.
7. Cárdenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, Vais H, Cheung KH, Yang J, Parker I, Thompson CB, Birnbaum MJ, Hallows KR, Foskett JK. 2010. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142: 270-283.
8. Chen C-C, Jeon S-M, Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, Tonic I, Park Y, Hay N. 2010. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of sestrin3 and rictor. Dev Cell 18: 592-604.
9. Cheung EC, Vousden KH. 2010. The role of p53 in glucose metabolism. Curr Opin Cell Biol 22: 186-191.
10. Das A, Banik NL, Ray SK. 2010. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer 116: 164-176.
11. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J, Gunter TE. 2009. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 284: 9692-9699.
12. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB. 2004. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899.
13. Fadeel B, Ottosson A, Pervaiz S. 2007. Big wheel keeps on turning: Apoptosome regulation and its role in chemoresistance. Cell Death Differ 15: 443-452.
14. Fulda S, Galluzzi L, Kroemer G. 2010. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9: 447-464.
15. Furuta E, Okuda H, Kobayashi A, Watabe K. 2010. Metabolic genes in cancer: Their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805: 141-152.
16. Gogvadze V, Robertson JD, Zhivotovsky B, Orrenius S. 2001. Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax. J Biol Chem 276: 19066-19071.
17. Gogvadze V, Zhivotovsky B, Orrenius S. 2010. The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 31: 60-74.
18. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. 2001. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418.
19. Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, Blanchard D, Gygi SP, Brunet A. 2007. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans Curr Biol 17: 1646-1656.
20. Hay N. 2010. Mnk earmarks eIF4E for cancer therapy. Proc Natl Acad Sci USA 107: 13975-13976.
21. Hockenbery DM. 2010. Targeting mitochondria for cancer therapy. Environ Mol Mutagen 51: 476-489.
22. Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. 2010. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. J Biol Chem 285: 15960-15965.
23. Kim J-w, Gao P, Liu YC, Semenza GL, Dang CV. 2007. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27: 7381-7393.
24. Kroemer G, Pouyssegur J. 2008. Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13: 472-482.
25. Kroemer G, White E. 2010. Autophagy for the avoidance of degenerative, inflammatory, infectious, and neoplastic disease. Curr Opin Cell Biol 22: 121-123.
26. Lee J, Kim SS. 2010. Current implications of cyclophilins in human cancer. Cancer Res 29: 97-102.
27. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, Xie M, Yin X, Livesey KM, Lotze MT, Tang D, Cao L. 2010. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 25: 23-31.
28. Mayevsky A. 2009. Mitochondrial function and energy metabolism in cancer cells: Past overview and future perspectives. Mitochondrion 9: 165-179.
29. Mazure NM, Pouysségur J. 2010. Hypoxia-induced autophagy: Cell death or cell survival? Curr Opin Cell Biol 22: 177-180.
30. Miyakawa T, Maeda A, Yamazawa T, Hirose K, Kurosaki T, Iino M. 1999. Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J 18: 1303-1308.
31. Norberg E, Orrenius S, Zhivotovsky B. 2010. Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 396: 95-100.
32. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. 2003. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23: 7315-7328.
33. Rodriquez D, Rojas-Rivera D, Hetz C. 2011. Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat. Biochim Biophys Acta - Mol Cell Res 1813: 564-574.
34. Rong Y-P, Aromolaran AS, Bultynck G, Zhong F, Li X, McColl K, Matsuyama S, Herlitze S, Roderick HL, Bootman MD, Mignery GA, Parys JB, De Smedt H, Distelhorst CW. 2008. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell 31: 255-265.
35. Scherz-Shouval R, Elazar Z. 2011. Regulation of autophagy by ROS: Physiology and pathology. Trends Biochem Sci 36: 30-38.
36. Schindler A, Foley E. 2010. A functional RNAi screen identifies hexokinase 1 as a modifier of type II apoptosis. Cell Signal 22: 1330-1340.
37. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 64: 2627-2633.
38. Semenza GL. 2009. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19: 12-16.
39. Semenza GL. 2010. HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20: 51-56.
40. Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR. 2010. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med 16: 671-677.
41. Shoshan-Barmatz V, Keinan N, Abu-Hamad S, Tyomkin D, Aram L. 2010. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: Release of cytochrome c, AIF and Smac/Diablo. Biochim Biophys Acta 1797: 1281-1291.
42. Shulga N, Pastorino JG. 2010. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J Cell Sci 123: 4117-4127.
43. Shulga N, Wilson-Smith R, Pastorino JG. 2009. Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle 8: 3355-3364.
44. Struys EA. 2005. Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause d-2-hydroxyglutaric aciduria. Am J Hum Genet 76: 358-360.
45. Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans AS, van Ginkel PR. 2010. Resveratrol: Challenges in translation to the clinic-A critical discussion. Clin Cancer Res 16: 5942-5948.
46. 2+signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol Cancer 9: 156.
47. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. 2010. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29: 5299-5310.
48. Wang F, Ogasawara MA, Huang P. 2010. Small mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med 31: 75-92.
49. Warburg O. 1926. Uber den Stoffwechsel der Tumore. Springer, Berlin. Translated: The Metabolism of Tumors, 1930. Arnold Constable, Lindon
50. Wenner CE. 2010. Cell signaling and cancer-possible targets for therapy. J Cell Physiol 223: 299-308.
51. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
52. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL. 2008. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903.